Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants
Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants
2018
Tarik Asselah
Stanislas Pol
Christophe Hézode
V. Loustaud-Ratti
Vincent Leroy
Si Nafa Si Ahmed
V. Ozenne
J.-P. Bronowicki
D. Larrey
Annelise Tran
Laurent Alric
E. Nguyen-Khac
Michael N. Robertson
George J Hanna
D. Brown
Ernest Asante-Appiah
S Ludmerer
M. Su
Peggy Hwang
S Klopfer
Frank J. Dutko
A. Guidoum
K. Hagen
Barbara Haber
Rohit Talwani
L. Serfaty
Keywords:
Virology
Elbasvir, Grazoprevir
Physical therapy
Medicine
Diabetes mellitus
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]